Delivery Order SPE2DR25D7064-SPE2DR26F2MNX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Thrombin-JMI 5,000 unit vials, with a ceiling value of $1,533.12. This is a firm fixed-price delivery order executed under a competitive, non-set-aside procurement. The contract is scheduled for ultimate completion by December 1, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Thrombin-JMI 5,000 unit vials. This competitively awarded, non-set-aside contract carries a ceiling value of $7,615.26 under a firm fixed-price delivery order arrangement, with an ultimate completion date of September 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for Thrombin-JMI 5,000 Units Vials with a ceiling value of $22,319.95. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for ultimate completion on November 25, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Thrombin-JMI 5,000 Units Vials with a ceiling value of $1,451.48. This firm fixed price delivery order, which represents a child contract under a larger indefinite delivery vehicle, will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility and is scheduled for completion by November 28, 2025. The award was not designated as a set-aside contract,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,895.82 on August 26, 2025, for the supply of Thrombin-JMI 5,000 units vials, with an ultimate completion date of August 27, 2025. This firm fixed price contract is non-competitive and non-set-aside, with performance to be executed at the company's corporate office location in Conshohocken, Pennsylvania. The award is funded through the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 20,000 unit vials of the drug Thrombin-JMI. The $2,598.40 firm fixed price contract has a completion date of December 30, 2022 and was awarded on December 29, 2022. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
- This federal contract award is for the delivery of 5,000-unit vials of Thrombin-JMI, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $10,872.51, was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on August 30, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 3, 2024. This award is not associated with a set-aside program. As...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,236.16 firm fixed-price contract is for the supply of 4,557,711,596 units of Thrombin-JMI, a 20,000-unit vial medication. The award was made on July 5, 2022, with a completion date of July 6, 2022. This contract is a task order under AmerisourceBergen's larger $999,999,999 Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Thrombin-JMI 20,000 Units Pumps on December 1, 2025, with a ceiling value of $1,488.35 and an ultimate completion date of December 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a relatively small-value transaction within the broader...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,221.58 Firm Fixed Price delivery order covers the supply of 20,000 unit vials of Thrombin-JMI, a critical medication. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. (parent company of Amerisourcebergen Drug Corp) holds with the DLA...
- SPE2DR25D7064Indefinite Delivery Contract
- SPE2DR25D7064-SPE2DR26F2MNXDelivery Order
The Defense Logistics Agency awarded a $3,195 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 5,000 units of Thrombin-JMI vials. This contract, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a small-value pharmaceutical procurement to support federal medical supply requirements. The award was made through open competition with no set-aside designation, leveraging AmerisourceBergen's established position as a critical vendor within the federal healthcare supply chain. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. This overarching IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, medical supplies, vaccines, and specialty pharmaceuticals to military healthcare systems and other federal agencies worldwide. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, maintains a significant federal contract portfolio with DLA for diverse therapeutic domains, demonstrating consistent capability to meet competitively awarded federal medical procurement requirements across varying transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 12/9/25 |